I

Integer Holdings Corporation

Medical device CDMO for cardiac devices

EHSS Engineer 3

Full-TimeUpdated on 10/23/2026
No salary listed
Mid, Senior
Pembroke Pines, FL, USA
In Person
Facilities OperationsEnvironmental Health & Safety

About the job

Requirements
  • Demonstrate the ability to learn, retain, and apply knowledge, through a bachelor's degree in environmental, natural, or equivalent science, engineering technology, occupational safety/industrial hygiene, or fire safety, or through accumulated EHSS learning and experience over 3–5 years.
  • Collaborate with other departments to meet common goals related to overall company strategy.
  • Have expanded knowledge of the physical properties and hazards of chemicals.
  • Be well organized, maintain good records, demonstrate interpersonal skills, and be able to take work direction.
  • Be proficient with Microsoft Office and electronic Safety Management Systems.
Responsibilities
  • Adhere to company values and all safety, environmental, security, and quality requirements, including Quality Management Systems, Safety, Environmental and Security Management Systems, U.S. Food and Drug Administration regulations, company policies and operating procedures, and other regulatory requirements.
  • Serve as the subject matter expert on EHSS matters related to associate safety, environmental protection, process safety, equipment safety, and security in a manufacturing environment.
  • Collaborate with the EHSS Manager and peers to implement site-specific EHSS strategy, programs, and initiatives to ensure compliance with EHSS policies and goals.
  • Monitor and evaluate the impact of new laws, regulations, and industry standards, and implement them into the site EHSS program.
  • Lead cross-functional teams to continuously achieve a safe and environmentally friendly work environment.
  • Ensure records, permits, and reports are maintained and prepared according to established guidelines by local, county, state, and country agencies.
  • Develop and implement training for new and existing Associates on company policies, procedures, and governmental regulations.
  • Lead the identification of hazardous workplace conditions by conducting documented job hazard analyses and coordinate corrective and preventative actions.
  • Respond to day-to-day Associate concerns in an appropriate and timely manner.
  • Manage investigations of serious work-related injuries and near-miss incidents; document findings, root cause analyses, and corrective actions; manage workers’ compensation claims; and ensure timely associate return to work.
  • Lead EHSS reviews, measures, audits, and reports assigned by the EHSS Manager to attain and maintain compliance with EHSS laws, regulations, company policies, and best practices.
  • Lead and train the Emergency Response Team to be proficient in facility needs including hazardous materials, incipient fire, medical, or other potential emergencies.
  • Act as liaison to government agencies, emergency responders, and customers.
  • Perform other functions as required.
  • Lead several elements of the EHSS program with site associates, focusing on EHSS engagement goals including safety committees or teams, ergonomics, management safety audits, recurring EHSS inspections, Behavioral Based Safety, and special skills or certifications.
  • Promote associate safety engagement by encouraging observations and suggestions and reporting near-miss incidents.
  • Lead or work with the EHSS Manager to assess new equipment and chemicals coming on site.
  • Lead EHSS internal self-assessments as directed by the EHSS Manager.
  • Participate in internal and external inspections as needed to maintain compliance with EHSS requirements.
Desired Qualifications
  • Professional certifications such as Certified Safety Professional or Certified Industrial Hygienist.
  • First Aid, CPR, AED, Laser Safety Officer, Forklift Trainer, or other relevant EHSS certifications.

About the company

I

Integer Holdings Corporation

View

Integer Holdings Corporation is a large medical device contract development and manufacturing organization (CDMO) that supports medical device makers in cardiac rhythm management, neuromodulation, and cardiovascular markets. It provides end-to-end services from design support to manufacturing, delivering components and finished subsystems such as implants, housings, electrodes, and batteries through its Greatbatch Medical, Lake Region Medical, and Electrochem brands. The company differentiates itself by its scale, breadth of capabilities across multiple medical specialties, established brand portfolio, and global manufacturing footprint that enable reliable, integrated supply. Its goal is to improve patients’ lives worldwide by helping customers bring safe and effective medical technologies to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Wilmington, Delaware

Founded

1940

Get referred to Integer Holdings Corporation

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q2 2026 revenue hit $464.1 million, beating estimates despite weak medtech demand.
  • Integer expects demand recovery after New Ross's July 27-August 10, 2026 shutdown.
  • KKR plans new capacity, technology, and employee ownership after closing by year-end 2026.

What critics are saying

  • Integer withdrew 2026 guidance on August 3, 2026, after KKR announced the buyout.
  • Schall, Brown & Schwartz opened an August 23, 2026 fiduciary-duty investigation.
  • Regulatory or stockholder rejection kills the KKR deal and leaves Integer's weak standalone outlook exposed.

What makes Integer Holdings Corporation unique

  • Integer's R&D Velocity integrates design, prototyping, and manufacturing for complex medtech programs.
  • Its 33-facility global network spans electrophysiology, neuromodulation, and structural heart.
  • KKR's August 3, 2026, $5.7 billion bid validates Integer's scale and customer lock-in.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Life Insurance
  • Disability Insurance
  • Adoption Assistance
  • Parental Leave
  • 401(k) Company Match
  • 401(k) Retirement Plan
  • Paid Vacation
  • Paid Holidays

Growth & Insights and Company News

6 month growth

0%

1 year growth

-2%

2 year growth

-1%
Ticker Report
Aug 29th, 2026
Boussard & Gavaudan Gestion Sas Makes New $2.60 Million Investment in Integer Holdings Corporation $ITGR

Boussard & Gavaudan Gestion Sas bought a new position in Integer Holdings Corporation (NYSE:ITGR – Free Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 28,153 shares of the medical equipment provider’s stock, valued at approximately $2,597,000. Other institutional investors and hedge funds also […]

Yahoo Finance
Aug 16th, 2026
Healthcare stocks outpace S&P 500 by 13 percentage points over six months

Healthcare stocks have returned 26.1% over the past six months, outperforming the S&P 500 by 13.1 percentage points. However, investors must remain cautious due to heavy regulation affecting earnings potential. Integer Holdings faces concerns with 6.1% annual revenue growth over two years, lagging healthcare peers. Its modest revenue base of $1.84 billion provides less fixed cost leverage than larger competitors. The company trades at $125.07 per share, or 18.6 times forward price-to-earnings. Evolent Health shows weak platform performance and declining returns on capital. Its high net-debt-to-EBITDA ratio of 7 times could force unfavourable capital raises if market conditions worsen. Shares trade at $4.15, representing 12.4 times forward price-to-earnings. Tenet Healthcare, operating hospitals and surgical centres across nine US states, emerges as the recommended healthcare investment.

Yahoo Finance
Aug 4th, 2026
Integer Holdings acquired by KKR for $5.7B in all-cash deal at $127 per share

Integer Holdings agreed to be acquired by private equity firm KKR in an all-cash deal valued at approximately $5.7 billion. The transaction values the medical technology company at $127 per share. Shares jumped 2.7% in afternoon trading, continuing a rally from the previous session when the stock surged over 20% following the announcement. The acquisition news overshadowed strong second-quarter results, where Integer posted an adjusted profit of $1.60 per share on $464.1 million in revenue, surpassing analyst estimates. Following the buyout announcement, Integer withdrew its previously issued financial guidance and cancelled its upcoming earnings conference call. Shares traded at $124.50, marking a new 52-week high.

BizWire Express
Aug 3rd, 2026
KKR to acquire Integer for $5.7B in all-cash deal at $127 per share

KKR has agreed to acquire Integer Holdings Corporation, a medical device contract development and manufacturing organisation, in an all-cash transaction valued at approximately $5.7 billion. Integer stockholders will receive $127 per share, representing a 51.8% premium to the company's closing share price on 29 April 2026. The acquisition follows a comprehensive strategic review announced by Integer in April 2026. The Integer Board unanimously approved the agreement and recommends stockholder approval. KKR plans to invest in Integer's capacity, technology, innovation, and talent. The firm also intends to establish a broad-based employee ownership programme following the transaction's close, consistent with its approach across portfolio companies. The transaction is expected to close by year-end, subject to stockholder approval and regulatory clearances. Upon completion, Integer will become privately held and delist from the New York Stock Exchange.

Yahoo Finance
Aug 3rd, 2026
Integer Holdings beats Q2 expectations with $464M revenue and $1.60 earnings per share

Integer Holdings Corp. reported second-quarter net income of $23.6 million, or 69 cents per share. Adjusted earnings came to $1.60 per share, exceeding Wall Street expectations of $1.38 per share. The Plano, Texas-based medical device outsource manufacturer posted revenue of $464.1 million for the period, also beating analyst forecasts of $452.5 million. The results surpassed predictions from five analysts surveyed by Zacks Investment Research on both earnings and revenue metrics.